Valiant Organics Exits Partnership, Gains Valiant Laboratories Stake

Valiant Organics Limited will receive 18,607,531 equity shares of Valiant Laboratories Limited.
DVLLP's turnover was ₹0.3756 crore in FY2026, contributing 0.05% to consolidated turnover.

What Happened

Valiant Organics Limited's Board of Directors has approved the company's exit from its partnership in Dhanvallabh Ventures LLP (DVLLP). As part of this exit, DVLLP will transfer 18,607,531 equity shares of Valiant Laboratories Limited to Valiant Organics. This transaction will result in DVLLP no longer being a subsidiary of Valiant Organics Limited.

Why It Matters

This move signifies a strategic shift for Valiant Organics, allowing it to streamline operations and consolidate its stake in Valiant Laboratories. The transaction is considered a material related party deal and will be executed at fair market value, subject to shareholder approval. The exit means DVLLP will no longer be consolidated under Valiant Organics' financial statements.

The Backstory

Dhanvallabh Ventures LLP (DVLLP) had a turnover of ₹0.3756 crore in fiscal year 2026, making up only 0.05% of Valiant Organics' consolidated turnover. However, its net worth as of March 31, 2026, was ₹83.79 crore, representing 11.34% of the consolidated net worth. A valuation report for this transaction was dated May 19, 2026.

Changes Ahead

After the transaction, Valiant Organics will no longer be a partner in DVLLP, and DVLLP will cease to be its subsidiary. The primary change is Valiant Organics' significant acquisition of Valiant Laboratories Limited equity shares as consideration for exiting DVLLP.

Potential Risks

This transaction depends on receiving necessary shareholder and regulatory approvals. Definitive agreements for the partnership cessation and share transfer must also be finalized. Completion is expected within 60 days after shareholder approval, provided all conditions are met.

What to Track Next

Investors will be monitoring the shareholder approval process, the finalization of transaction documents, and the effective date of the share transfer and DVLLP's change in subsidiary status.